Loss per share |
3 Months Ended | |
---|---|---|
Mar. 31, 2020 | ||
Loss per share | ||
Loss per share |
Note 5 — Loss per share
The dilutive effect of 93,106,607 and 103,848,778 stock options outstanding as of March 31, 2020 and 2019 respectively have been excluded from the diluted loss per share calculation for the three months ended March 31, 2020 and 2019 respectively, because they would have an antidilutive effect on the loss per share for the period. |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The entire disclosure for earnings per share. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|